Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

polydopamine-coated siRNA-absorbed doxorubicin/paclitaxel-encapsulated poly(2-(2-methoxyethoxy)ethyl methacrylate-co-oligo (ethylene glycol) methacrylate)-co-2-(dimethylamino)ethyl methacrylate-b-poly(lactic-co-glycolic acid) nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

1

siRNA-absorbed doxorubicin/paclitaxel-encapsulated poly(2-(2-methoxyethoxy)ethyl methacrylate-co-oligo (ethylene glycol) methacrylate)-co-2-(dimethylamino)ethyl methacrylate-b-poly(lactic-co-glycolic acid) nanoparticles

doxorubicin/paclitaxel/siRNA-loaded poly(2-(2-methoxyethoxy)ethyl methacrylate-co-oligo (ethylene glycol) methacrylate)-co-2-(dimethylamino)ethyl methacrylate-b-poly(lactic-co-glycolic acid) nanocapsules DOX/PX/siRNA-loaded P(MEO2MA-co-OEGMA-co-DMAEMA)-b-PLGA core-shell nanostructures
Type Nano Material
Formula
Role core
2

PDA

Type Polymer
Formula
Role layer

Properties

General physical and chemical properties

Property Value Source
colloidal stability

1 more entry available to subscribers only.

Or, view sample content

Applications

Characterization

Method Source
dynamic light scattering

0 more entry available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Product

polydopamine-coated siRNA-absorbed doxorubicin/paclitaxel-encapsulated poly(2-(2-methoxyethoxy)ethyl methacrylate-co-oligo (ethylene glycol) methacrylate)-co-2-(dimethylamino)ethyl methacrylate-b-poly(lactic-co-glycolic acid) nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial